Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Small Pharma Inc (OP: DMTTF ) N/A UNCHANGED Last Price Updated: 3:59 PM EDT, Oct 20, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Small Pharma Inc < Previous 1 2 3 4 5 6 7 8 Next > Psychedelic Stock Gainers And Losers From January 18, 2022 January 18, 2022 GAINERS: Cybin (AMEX: Via Benzinga Marijuana & Psychedelic Drug Stocks Continue To Decline January 16, 2022 The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are... Via Talk Markets Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High January 09, 2022 There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents. Via Talk Markets Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November December 01, 2021 A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance. Via Talk Markets Topics Cannabis Exposures Cannabis Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2021 November 08, 2021 Upgrades For Nektar Therapeutics (NASDAQ: Via Benzinga Compass Pathways 2.0: A New Rally In Psychedelic Stocks? November 04, 2021 Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? Via Talk Markets Topics Initial Public Offering Exposures Securities Market Small Pharma Receives European Patent Of Ketamine-Based Compounds For Treatment of Depressive Disorders October 27, 2021 Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF), a neuropharmaceutical company focused on psychedelic-assisted therapies, announced on Tuesday, that it has received a European patent... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psyched: British PM Considers Psychedelics, New Partnership To Study Psilocybin For Autism, Compass Gets Another Patent October 26, 2021 The Week In Psychedelics Via Benzinga Psychedelic Stocks Rebounded 9% Last Week; Small Pharma Was Up 148% October 24, 2021 The Psychedelic Compounds-Based Drug Stocks Index was up +8.9% last week albeit still down -18.5% YTD. Via Talk Markets Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? October 23, 2021 The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. Via Talk Markets Phase 2 Trial On Ayahuasca's Active Ingredient Puts Small Pharma On Track To Winning The Psychedelics Race October 20, 2021 Small Pharma Inc. (OTCQB:DMTTF) (TSXV: Via Benzinga Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 October 15, 2021 Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month. Via Talk Markets Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.